Broad-led consortium receives ARPA-H award to advance gene editing for rare pediatric epilepsy

A consortium of 12 organizations, led by the Broad Institute, has been selected to receive funding from the Advanced Research Projects Agency for Health (ARPA-H) under its THRIVE program. The award, for up to $34.5 million, will fund the Pediatric Epilepsies and Rare CNS (PERC) Gene Editing Platform — a collaboration of academic researchers, clinicians, patient advocates, and biotechnology companies aiming to develop gene-editing treatments for children with rare forms of epilepsy.